Suppr超能文献

静脉输注丙泊酚的药代动力学。

Pharmacokinetics of propofol when given by intravenous infusion.

作者信息

Morgan D J, Campbell G A, Crankshaw D P

机构信息

Victorian College of Pharmacy, Parkville, Melbourne, Victoria, Australia.

出版信息

Br J Clin Pharmacol. 1990 Jul;30(1):144-8. doi: 10.1111/j.1365-2125.1990.tb03755.x.

Abstract

We have previously shown with i.v. bolus studies that the elimination of propofol is much slower than previously reported. Now we have studied the implications of this for prolonged i.v. infusion of propofol in seven patients who received continuous infusions of propofol for up to 9 h. Values of elimination half-life ranged from 13.1 to 44.7 h, systemic clearance from 1.02 to 1.63 l h-1 and volume of distribution from 1390 to 3940 l and these were similar to those obtained with bolus administration. The large volume of distribution is consistent with the high octanol/blood partition coefficient, which was found to be 72.0. Despite the very long elimination half-life, blood propofol concentrations appeared to approach steady state within 20 min rather than the 4-5 half-lives normally expected. This is because for this drug, which displays multicompartment pharmacokinetics, the rate of initial rise of blood concentrations is governed primarily by the very short distribution half-life of the drug. Therefore, the long elimination half-life of propofol is probably of little significance in designing infusions regimens, but the lower systemic clearance should be taken into account to avoid unwanted accumulation.

摘要

我们之前通过静脉推注研究表明,丙泊酚的消除比之前报道的要慢得多。现在我们研究了这一情况对7例接受丙泊酚持续输注长达9小时的患者长时间静脉输注丙泊酚的影响。消除半衰期的值在13.1至44.7小时之间,全身清除率在1.02至1.63升/小时之间,分布容积在1390至3940升之间,这些与静脉推注给药时获得的值相似。较大的分布容积与高辛醇/血液分配系数一致,该系数为72.0。尽管消除半衰期非常长,但丙泊酚血药浓度似乎在20分钟内接近稳态,而不是通常预期的4至5个半衰期。这是因为对于这种呈现多室药代动力学的药物,血药浓度的初始上升速率主要由药物非常短的分布半衰期决定。因此,丙泊酚长的消除半衰期在设计输注方案时可能意义不大,但较低的全身清除率应予以考虑以避免不必要的蓄积。

相似文献

1
Pharmacokinetics of propofol when given by intravenous infusion.静脉输注丙泊酚的药代动力学。
Br J Clin Pharmacol. 1990 Jul;30(1):144-8. doi: 10.1111/j.1365-2125.1990.tb03755.x.
2
Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients.
Anesthesiology. 1990 Aug;73(2):214-7. doi: 10.1097/00000542-199008000-00004.
4
Pharmacokinetics of propofol infusions in patients with cirrhosis.
Br J Anaesth. 1990 Aug;65(2):177-83. doi: 10.1093/bja/65.2.177.
5
Pharmacokinetics of propofol administered by infusion in dogs undergoing surgery.
Br J Anaesth. 1993 May;70(5):546-51. doi: 10.1093/bja/70.5.546.
8
Pharmacokinetic implications for the clinical use of propofol.丙泊酚临床应用的药代动力学影响
Clin Pharmacokinet. 1989 Nov;17(5):308-26. doi: 10.2165/00003088-198917050-00002.
9
Pharmacokinetics of propofol in children.
Br J Anaesth. 1990 Nov;65(5):661-7. doi: 10.1093/bja/65.5.661.

引用本文的文献

6
The use of PBPK modeling across the pediatric age range using propofol as a case.以丙泊酚为例,在儿科年龄范围内使用 PBPK 模型。
J Pharmacokinet Pharmacodyn. 2018 Dec;45(6):765-785. doi: 10.1007/s10928-018-9607-8. Epub 2018 Oct 8.
8
[Drugs for intravenous induction of anesthesia: propofol].[静脉麻醉诱导药物:丙泊酚]
Anaesthesist. 2018 Feb;67(2):147-162. doi: 10.1007/s00101-017-0397-y.

本文引用的文献

10
Disturbances in hepatic blood flow during anesthesia and surgery.麻醉和手术期间肝血流的紊乱。
Arch Surg. 1976 Aug;111(8):881-3. doi: 10.1001/archsurg.1976.01360260049012.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验